Skip to content

Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology

Evaluation of Laparoscopic Non Anatomical Liver Resection in Hepatic Pathology

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06166511
Enrollment
30
Registered
2023-12-12
Start date
2024-01-10
Completion date
2025-05-10
Last updated
2023-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Liver Resection

Brief summary

Laparoscopy is a type of surgical procedure that allows a surgeon to access the inside of the abdomen and pelvis without making large incisions in the skin.The use of laparoscopy in abdomenal surgeries increases for its great benefits over open surgery as: 1)faster recovery, 2)decrease blood loss, 3)shorter hospital stays, 4)decreased postoperative pain, 5)earlier return to work and resumption of normal daily activity as well as, 6)cosmetic benefits. few studies discuss the efficacy and safety of using Laparoscopy in liver non anatomical resection.

Detailed description

this study will include any male and female above 18 that presented with localized liver pathology (as benign hepatic tumours, resectable primary(HCC) or secondary malignancies, hydatid cyst any other hepatic cysts, haemangiomas,etc…...) and underwent laparoscopic non anatomical resection of liver in Assiut university hospitals. Investigators will record the time of operation, number of cases with intra operative mortality or complication and then follow up these patients during time of hospital stay for: 1\) post operative pain 2) secondary bleeding and 3) wound infection. Then follow up these patients in out patient clinic visit for their: 1. satisfaction 2. cosmetic outcomes and 3. rate of recurrence of the pathology.

Interventions

PROCEDURELaparoscopic liver resection

Using Laparoscopy in liver resection

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* any male or female above 18 that has one of the following pathologies and underwent non anatomical hepatic resection: * hepatic benign tumours as adenoma * resectable secondary malignancies (2) * any type of hepatic cysts e.g., hydatid cyst * HCC on top of liver cirrhosis.

Exclusion criteria

* 1\) any immunocompromised patient 2) Patient with contraindicdtions to use laparoscopy. 3) patient who are difficult to follow up.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of post operative complications2 yearsType and incidence of post operative complications
Incidence of intra operative complications2 yearsType of complications and Its incidence
Length of hospital stay2 yearsTime spended by cases in hospital
Incidence of intra operative mortality2 yearsNumber of cases die intra operative
Length of operation2 yearsTime of operation
Post operative pain2 yearsPain scale post operative

Secondary

MeasureTime frameDescription
Incidence of recurrence of pathology2 yearsNumber of cases with same pathology recurrence
Cosmetic outcome2 yearsPatient cosmetic sutisfacton

Countries

Egypt

Contacts

Primary ContactN N Adly
nadernasihadly@gmail.com01206187141
Backup ContactAbd El-moniem I El-khateeb, Prof
Profalelhateeb@gmail.com01005022533

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026